Annual Working Capital
$7.89 M
+$1.23 M+18.53%
December 31, 2023
Summary
- As of February 7, 2025, CANF annual working capital is $7.89 million, with the most recent change of +$1.23 million (+18.53%) on December 31, 2023.
- During the last 3 years, CANF annual working capital has fallen by -$243.00 thousand (-2.99%).
- CANF annual working capital is now -54.50% below its all-time high of $17.34 million, reached on December 31, 2021.
Performance
CANF Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$3.84 M
-$4.05 M-51.31%
June 30, 2024
Summary
- As of February 7, 2025, CANF quarterly working capital is $3.84 million, with the most recent change of -$4.05 million (-51.31%) on June 30, 2024.
- Over the past year, CANF quarterly working capital has dropped by -$4.83 million (-55.73%).
- CANF quarterly working capital is now -77.85% below its all-time high of $17.34 million, reached on December 31, 2021.
Performance
CANF Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CANF Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.5% | -55.7% |
| 3 y3 years | -3.0% | -46.6% |
| 5 y5 years | +64.9% | -60.4% |
CANF Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.5% | +18.5% | -77.8% | at low |
| 5 y | 5-year | -54.5% | +103.7% | -77.8% | at low |
| alltime | all time | -54.5% | +1164.7% | -77.8% | +618.4% |
Can-Fite BioPharma Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $3.84 M(-51.3%) |
| Dec 2023 | $7.89 M(+18.5%) | $7.89 M(+15.1%) |
| Sep 2023 | - | $6.85 M(-21.0%) |
| Jun 2023 | - | $8.68 M(-17.3%) |
| Mar 2023 | - | $10.49 M(+57.6%) |
| Dec 2022 | $6.66 M(-61.6%) | $6.66 M(-31.9%) |
| Sep 2022 | - | $9.77 M(-21.4%) |
| Jun 2022 | - | $12.44 M(-15.8%) |
| Mar 2022 | - | $14.77 M(-14.8%) |
| Dec 2021 | $17.34 M(+113.2%) | $17.34 M(+40.7%) |
| Sep 2021 | - | $12.32 M(+71.3%) |
| Jun 2021 | - | $7.19 M(-31.9%) |
| Mar 2021 | - | $10.57 M(+29.9%) |
| Dec 2020 | $8.13 M(+109.9%) | $8.13 M(-28.8%) |
| Sep 2020 | - | $11.42 M(+1.9%) |
| Jun 2020 | - | $11.20 M(+189.3%) |
| Dec 2019 | $3.87 M(-19.0%) | - |
| Dec 2019 | - | $3.87 M(-43.3%) |
| Sep 2019 | - | $6.83 M(-29.6%) |
| Jun 2019 | - | $9.70 M(+104.9%) |
| Mar 2019 | - | $4.74 M(-1.0%) |
| Dec 2018 | $4.78 M(-2.6%) | - |
| Dec 2018 | - | $4.78 M(-34.9%) |
| Sep 2018 | - | $7.34 M(+5.4%) |
| Jun 2018 | - | $6.97 M(-22.3%) |
| Mar 2018 | - | $8.97 M(+82.7%) |
| Dec 2017 | $4.91 M | - |
| Dec 2017 | - | $4.91 M(-33.0%) |
| Sep 2017 | - | $7.33 M(-15.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $8.63 M(-16.0%) |
| Mar 2017 | - | $10.28 M(+35.2%) |
| Dec 2016 | $7.60 M(-51.8%) | - |
| Dec 2016 | - | $7.60 M(-25.0%) |
| Sep 2016 | - | $10.14 M(-16.6%) |
| Jun 2016 | - | $12.16 M(-14.9%) |
| Mar 2016 | - | $14.29 M(-9.3%) |
| Dec 2015 | $15.76 M(+81.9%) | - |
| Dec 2015 | - | $15.76 M(+15.0%) |
| Sep 2015 | - | $13.70 M(+93.6%) |
| Jun 2015 | - | $7.08 M(-5.0%) |
| Mar 2015 | - | $7.45 M(-14.0%) |
| Dec 2014 | $8.66 M(+94.9%) | - |
| Dec 2014 | - | $8.66 M(+158.3%) |
| Sep 2014 | - | $3.35 M(-34.1%) |
| Jun 2014 | - | $5.09 M(-28.4%) |
| Mar 2014 | - | $7.11 M(+60.1%) |
| Dec 2013 | $4.44 M(-699.8%) | $4.44 M(+158.9%) |
| Sep 2013 | - | $1.72 M(-41.8%) |
| Jun 2013 | - | $2.95 M(-29.9%) |
| Mar 2013 | - | $4.21 M(-668.2%) |
| Dec 2012 | -$740.90 K(-121.3%) | - |
| Dec 2012 | - | -$740.90 K(-160.5%) |
| Sep 2012 | - | $1.22 M(-47.3%) |
| Jun 2012 | - | $2.32 M(+7.0%) |
| Mar 2012 | - | $2.17 M(-37.6%) |
| Dec 2011 | $3.48 M | - |
| Dec 2011 | - | $3.48 M(+1715.5%) |
| Sep 2011 | - | $191.50 K |
FAQ
- What is Can-Fite BioPharma annual working capital?
- What is the all time high annual working capital for Can-Fite BioPharma?
- What is Can-Fite BioPharma annual working capital year-on-year change?
- What is Can-Fite BioPharma quarterly working capital?
- What is the all time high quarterly working capital for Can-Fite BioPharma?
- What is Can-Fite BioPharma quarterly working capital year-on-year change?
What is Can-Fite BioPharma annual working capital?
The current annual working capital of CANF is $7.89 M
What is the all time high annual working capital for Can-Fite BioPharma?
Can-Fite BioPharma all-time high annual working capital is $17.34 M
What is Can-Fite BioPharma annual working capital year-on-year change?
Over the past year, CANF annual working capital has changed by +$1.23 M (+18.53%)
What is Can-Fite BioPharma quarterly working capital?
The current quarterly working capital of CANF is $3.84 M
What is the all time high quarterly working capital for Can-Fite BioPharma?
Can-Fite BioPharma all-time high quarterly working capital is $17.34 M
What is Can-Fite BioPharma quarterly working capital year-on-year change?
Over the past year, CANF quarterly working capital has changed by -$4.83 M (-55.73%)